Hospital Settling Bacteria Testing: Settle Plate Method, Standards, and Applications

Hospital settling bacteria testing is a passive air microbiological monitoring method that measures the deposition of viable airborne microorganisms onto open agar plates, and it is a core requirement for infection control in clean operating rooms, intensive care units, sterile supply areas, and hospital pharmacy cleanrooms. This article explains the testing principle, applicable standards such as GB 50333, GB 15982, GB/T 16294 and ISO 14698, sampling procedures, acceptance criteria, quality controls, and practical applications in hospital hygiene management.

Technical Overview

Settling bacteria (settle plate) testing is a passive air sampling technique used to quantify the number of viable microorganisms that deposit from the air onto a standard agar surface within a defined exposure period. In hospital environments, airborne bacteria, fungal spores, and skin scales shed by personnel can settle onto surgical incisions, sterile instruments, implants, and prepared infusions, directly contributing to healthcare-associated infections (HAIs). Settle plate testing therefore evaluates the microbial deposition risk at the critical working height and provides a simple, low-cost, and internationally recognized index of air hygiene quality.

Settle plate testing is complementary to active (impaction) air sampling for airborne viable particles: passive sampling reflects the deposition of microorganisms onto surfaces, which is the most relevant contamination pathway for wounds and exposed sterile items, while active sampling estimates the concentration of colony-forming units per cubic meter of air. Both approaches are specified in national and international standards, and hospital monitoring programs typically combine them or select the method prescribed by the applicable standard.

The main standards and guidelines governing hospital settling bacteria testing include:

• GB 50333, the technical code for hospital clean operating departments, which defines cleanliness classes and settling bacteria limits for operating rooms;
• GB 15982, the hygienic standard for disinfection in hospitals, which classifies hospital environments into risk classes and specifies air microbial limits;
• GB/T 16294, the test method for settling microorganisms in cleanrooms of the pharmaceutical industry, widely referenced for methodology;
• ISO 14698-1 and ISO 14698-2, which specify biocontamination control and the evaluation of microbiological data in controlled environments;
• ISO 14644-1 and ISO 14644-2, which govern the associated particulate cleanliness classification and periodic verification of cleanrooms;
• WS/T 367 and related hospital disinfection technical specifications, together with sterile supply (CSSD) standards, which define monitoring frequencies and procedures;
• GMP annexes on sterile manufacturing and pharmacy cleanroom practice, which specify settle plate exposure times of up to four hours for graded clean zones such as hospital intravenous admixture services.

Testing Samples

Because the test object is the air within controlled hospital environments, "samples" are defined as specific locations and environmental states where settle plates are exposed. Typical sampling locations include the following categories.

Clean Operating Rooms and Operating Departments

Operating rooms of all cleanliness classes (special cleanliness, standard cleanliness, general cleanliness, and quasi-cleanliness), including orthopedic joint replacement and organ transplant theaters, cardiac and neurosurgical theaters, laminar-flow wards, and the surgical zones and surrounding areas defined in cleanroom layouts. Sampling is performed at working height within the sterile field and surrounding zones to verify the performance of the laminar airflow and HVAC systems.

High-Risk Clinical Areas

Intensive care units (ICU, CCU, NICU, PICU), protective isolation rooms, burn wards, bone marrow transplant wards, delivery rooms, premature infant nurseries, and hematology oncology wards. These environments require stricter air hygiene because patients are highly susceptible to infection.

Central Sterile Supply Departments (CSSD)

Sterile storage areas, packing rooms, and disinfection zones where sterile instruments and implants are handled and stored, monitored to confirm that storage conditions maintain microbiological safety.

Hospital Pharmacy Cleanrooms

Pharmacy intravenous admixture services (PIVAS), cytotoxic drug preparation rooms, and sterile compounding areas, where settle plate monitoring follows cleanroom qualification practice with longer exposure durations to demonstrate continuous control during compounding operations.

General Clinical and Diagnostic Areas

Treatment rooms, dressing and injection rooms, dialysis rooms, endoscope reprocessing rooms, dental operatories, emergency departments, clinical laboratories, and infectious disease wards, monitored according to the environmental risk class assigned by the hospital hygiene standard.

Testing Items

The core testing item is the total settling bacterial count, reported as colony-forming units per plate per exposure period, typically expressed as CFU per exposure duration per 90 mm plate (for example, CFU/(30 min·90 mm plate)). Depending on the monitoring objective, the scope can be extended as follows:

• Total aerobic settling bacterial count on tryptic soy agar, the primary hygiene indicator;
• Settling fungal count (yeasts and molds) on Sabouraud dextrose agar, relevant for humid environments and immunocompromised patient areas;
• Detection of specified pathogenic microorganisms, such as coagulase-positive Staphylococcus aureus and beta-hemolytic streptococci, which must not be detected in key hospital environments under the hospital hygiene standard;
• Optional microbial identification of representative colonies (by biochemical methods or molecular typing) for infection outbreak tracing and root cause analysis;
• Comparative evaluation before and after terminal disinfection, filter replacement, or cleanroom renovation to verify corrective effectiveness.

Testing Methods

Principle

Gravity-driven deposition is used as the collection mechanism. A sterile agar plate of defined diameter (commonly 90 mm) filled with a measured volume of culture medium is opened at the sampling point, and the agar surface is exposed to the ambient air for a specified time. Airborne viable particles deposit onto the agar, and after incubation each viable unit forms a visible colony that is counted and related to the exposure time and plate area.

Media, Consumables, and Equipment

Tryptic soy agar (soybean casein digest agar) is used for total bacterial counts; Sabouraud dextrose agar is used for fungi. Where disinfectant residues may be present, media supplemented with neutralizing agents such as lecithin and polysorbate are preferred to avoid false-negative results. All media must pass sterility checks and growth promotion tests before use, and incubators must be calibrated. Sterile blank plates exposed at the preparation site serve as negative controls, and standard environmental monitoring records document lot numbers, exposure times, and incubation conditions.

Sampling Conditions

Testing is performed under a defined environmental state: static testing is conducted after cleaning and disinfection, before the start of clinical work, with doors and windows closed, air purification systems running at normal operating conditions, and personnel absent or minimized; dynamic testing is performed during actual operations when the operational contamination profile must be assessed. Sampling should avoid direct air currents from supply diffusers where not intentionally part of the assessment, and should be scheduled at a suitable interval after ultraviolet or chemical disinfection so that residuals do not suppress colony formation.

Sampling Point Layout

The number and position of settle plates follow the applicable standard. For pharmaceutical-style cleanroom verification, the minimum number of sampling points is typically the square root of the cleanroom area in square meters, rounded up, with plates placed at working height (approximately 0.8 to 1.5 m above the floor) at representative working positions. For clean operating rooms, plates are distributed between the surgical zone and the surrounding area in accordance with the cleanliness class layout specified in the clean operating department code. For general hospital environments, plates are placed diagonally at representative positions away from walls, doors, and obvious heat sources.

Exposure and Incubation Procedure

• Transport sterilized plates to the sampling point and allow them to equilibrate to room temperature;
• Label each plate with location, exposure start time, and operator;
• Open the plate, place the lid face down beside the dish, and expose the agar surface for the specified duration: 30 minutes for clean operating room monitoring per the operating department code; 30, 15, or 5 minutes depending on the environmental risk class per the hospital hygiene standard; and up to 4 hours (or a validated shorter time) for graded cleanrooms in pharmacy applications;
• Close the lid at the end of the exposure period and record the finish time;
• Incubate bacterial plates at 30 to 35 degrees Celsius for at least 48 hours (typically 48 to 72 hours); incubate fungal plates at 20 to 25 degrees Celsius for 5 to 7 days;
• Count colonies with a colony counter or by qualified visual counting, and verify results against negative controls.

Result Expression and Acceptance Criteria

Results are reported as CFU per plate for the stated exposure time and plate diameter. Where an estimated airborne concentration is required, the classical Omeliancki relationship may be applied to convert settle counts to an approximate CFU per cubic meter value, recognizing that the conversion is an approximation influenced by particle size and air movement. Typical acceptance criteria include:

• Clean operating rooms: settling bacteria limits of 0.2, 0.75, 2, and 5 CFU per 30 minutes per 90 mm plate in the surgical zone for cleanliness classes I through IV respectively, with corresponding limits in the surrounding area;
• Hospital environmental classes: a maximum of 4 CFU per plate with exposure times of 30 minutes, 15 minutes, or 5 minutes according to the risk class of the environment, together with the requirement that specified pathogens must not be detected;
• Graded cleanrooms in pharmacy practice: action limits such as fewer than 1 CFU per 4 hours for the highest grade zones, with progressively higher limits for lower grades, and results evaluated against both alert and action levels as part of a contamination control strategy.

Quality Control and Precautions

Analysts must be trained in aseptic technique and wear appropriate cleanroom garments to avoid contaminating the plates. Blank control plates accompany each sampling campaign, and any growth on blanks invalidates or flags the batch. Incubators, timers, and thermometers must be within calibration. Deviations such as interrupted exposure, accidental contact, or damaged plates must be documented. When results exceed limits, an investigation should review HVAC filter integrity, differential pressure and airflow velocity, cleaning and disinfection records, personnel behavior and gowning, and equipment layout, followed by corrective actions and retesting to confirm restoration of compliance.

Applications

Settling bacteria testing supports a wide range of hospital quality, safety, and compliance activities:

• Acceptance testing and periodic verification of newly built or renovated clean operating departments and laminar-flow wards;
• Routine infection control surveillance of high-risk departments as required by hospital hygiene standards and accreditation programs;
• Evaluation of terminal disinfection effectiveness in isolation wards and after management of infectious patients;
• Verification of HVAC maintenance activities such as high-efficiency filter replacement, duct cleaning, and airflow rebalancing;
• Qualification and routine monitoring of hospital pharmacy cleanrooms for sterile and hazardous drug compounding;
• Monitoring of CSSD sterile storage environments to safeguard instrument sterility;
• Epidemiological investigation and source tracing during suspected airborne transmission events or infection clusters;
• Regulatory inspections, hospital grading reviews, and documentation of a functioning microbiological environmental monitoring program;
• Training and process improvement, using trend data to optimize cleaning frequencies, traffic control, and behavior in controlled areas.

FAQ

What is the difference between settling bacteria and airborne viable bacteria testing?

Settling bacteria testing is a passive method in which microorganisms deposit by gravity onto an open agar plate, measuring the deposition rate onto surfaces such as wounds and instruments. Airborne viable bacteria testing uses an impaction air sampler to draw a known volume of air through the device, reporting the concentration in CFU per cubic meter. The two methods answer different questions and are prescribed for different environments by the applicable standards; many programs use both for a complete picture.

How long should settle plates be exposed?

The exposure time is defined by the governing standard: 30 minutes for clean operating rooms, class-dependent exposures of 30, 15, or 5 minutes for general hospital environments, and up to 4 hours for graded pharmaceutical cleanrooms. Longer exposure improves sensitivity for very clean environments, while media desiccation limits the maximum practical exposure time.

When and where should sampling be performed?

Static sampling is typically performed after cleaning and disinfection and before the working day begins, with the purification system running normally. Dynamic sampling is used when the contamination level during actual procedures must be known. Plates are placed at working height at representative positions, including the sterile field in operating rooms, in accordance with the layout rules of the applicable standard.

Can settle plate results be converted to CFU per cubic meter?

An approximate conversion can be made using the classical Omeliancki formula, which relates colony count, plate area, and exposure time to an estimated airborne concentration. However, because deposition depends on particle size and local air movement, the conversion is indicative rather than exact, and the primary reported result should remain CFU per exposure per plate.

What should be done if results exceed the limits?

An out-of-limit result should trigger a documented investigation covering high-efficiency filter condition and sealing, airflow velocity and differential pressures, cleaning and disinfection procedures and agents, personnel gowning and behavior, and sampling validity. Corrective actions are implemented, followed by retesting to confirm compliance, and results are trended to detect gradual deterioration before limits are breached.

How often should hospital settling bacteria monitoring be performed?

Frequency is defined by the applicable standards and the hospital infection control program. High-risk areas such as clean operating departments, ICUs, and pharmacy cleanrooms are generally monitored on a monthly to quarterly routine basis, with additional event-driven testing after construction, filter replacement, disinfection process changes, or suspected infection incidents, and full requalification after renovation of controlled areas.

Why must pathogenic bacteria not be detected in key environments?

Standards for hospital environments require that specified pathogens such as coagulase-positive Staphylococcus aureus and beta-hemolytic streptococci are absent from air samples in critical care and clean areas, because these organisms are directly associated with surgical site and nosocomial respiratory infections. Their detection indicates a breach in contamination control requiring immediate corrective action regardless of the total count.